Anti-doping agencies love an easy win. When a headline drops announcing a two-year ban for a Paralympic athlete over a failed drug test, the collective sports media nods in righteous approval. The system works, they tell us. Clean sport prevails. Integrity is restored.
It is a comfortable narrative. It is also completely delusional.
The recent suspension of British Paralympian Daphne Schrager following a medication oversight exposes the glaring absurdities built into modern anti-doping enforcement. We treat administrative oversights with the same moral outrage reserved for systematic, state-sponsored blood doping rings. In doing so, regulatory bodies like UK Anti-Doping (UKAD) and the World Anti-Doping Agency (WADA) prove they care far more about the appearance of compliance than the reality of human performance and medical necessity.
We are punishing athletes not for cheating, but for failing to navigate a bureaucratic nightmare designed by lawyers who have never trained a day in their lives.
The Therapeutic Use Exemption Trap
Let us dissect what actually happens when an athlete gets hit with a strict-liability ban. Standard anti-doping protocol dictates that the presence of a prohibited substance—regardless of intent, dosage, or performance benefit—equals guilt. End of story.
In elite parasport, this rigid dogma collides headfirst with biological reality. Athletes with complex neurological, musculoskeletal, or cardiovascular conditions routinely require targeted pharmacological interventions just to maintain basic physiological stability.
To remain compliant, these athletes must file a Therapeutic Use Exemption (TUE). Sounds simple on paper. In practice, the TUE framework is a labyrinth of shifting deadlines, vague documentation requirements, and arbitrary medical reviews.
Imagine a scenario where an athlete with cerebral palsy takes a prescribed medication to control muscle spasticity. The drug appears on the prohibited list. The athlete submits medical records, physician letters, and history of diagnosis. Yet, if an administrative detail is misplaced, or if a doctor checks the wrong box on a form during a routine prescription renewal, the athlete transforms overnight from a dedicated competitor into an outcast.
That is not catching a cheat. That is a bureaucrat celebrating a typo.
Strict Liability Is Broken
The foundational principle of modern anti-doping code is "strict liability." You are responsible for whatever enters your body. No excuses.
This policy was forged to stop cold-war era athletes from claiming their coach gave them "vitamins" that happened to contain oral turinabol. It was meant to eliminate plausible deniability for deliberate bad actors.
Applying strict liability with zero nuance to therapeutic treatments in parasport is fundamentally lazy. It equates intent with accident. It treats a missed paperwork filing the same as a micro-dosing protocol designed to cheat the system.
I have spent decades watching sports governance structures operate from the inside. When a governing body hits a minor athlete or a parasport competitor with a two-year ban over a prescription misstep, it is not demonstrating strength. It is burning down a house to kill a spider so it can report a successful pest control operation to shareholders.
Strict liability creates a false equivalence:
- Deliberate Doping: Sourcing prohibited compounds, designing masking cycles, and actively evading testers to gain an unfair physical edge.
- Procedural Non-Compliance: Taking a doctor-prescribed medication necessary for daily health management, but failing to secure a signed TUE prior to an out-of-competition test.
Lumping these two behaviors into the same disciplinary bucket is a failure of basic justice.
The Performance Myth in Parasport
When mainstream sports commentators discuss banned substances, they automatically assume performance enhancement. Put anabolic steroids in a sprinter, and they run faster. Put EPO in a cyclist, and they climb higher.
In parasport, the biological baseline is fundamentally different. A medication that relaxes involuntary muscle spasms or regulates blood pressure does not give a disabled athlete superhuman ability. It brings them closer to a functional baseline where they can safely train without suffering long-term physical damage.
When anti-doping authorities punish an athlete for taking medication that addresses an underlying impairment, they are not protecting "fair play." They are penalizing the athlete for their impairment.
The sports landscape refuses to acknowledge this truth: Equating therapeutic medical management with malicious performance enhancement is inherently discriminatory.
The High Cost of Regulatory Dogma
Why does WADA enforce these rules with such rigid fanaticism? Because nuance requires work. Nuance requires evaluating medical necessity case-by-case, hiring independent clinicians instead of enforcement lawyers, and admitting that the rules written for able-bodied powerlifters do not make sense for parasport competitors.
Slamming an athlete with a two-year suspension destroys a career. Two years out of a four-year Paralympic cycle wipes out an entire competitive lifespan. Peak physical windows are narrow. Sponsorships vanish. Mental health deteriorates.
All because an authority figure preferred enforcing a rigid rule over applying common sense.
Of course, critics will argue that loosening TUE enforcement creates loopholes. "If you allow leniency for paperwork, real cheats will hide behind medical excuses."
This argument is a cop-out. Modern mass spectrometry and biological passport tracking are fully capable of distinguishing between chronic therapeutic administration and acute, performance-enhancing micro-doses. The technology exists to spot the difference. The administrative courage to act on that data does not.
Rebuilding a Broken System
If sports integrity organizations actually cared about fairness rather than headline metrics, they would dismantle the current TUE framework today and rebuild it around three core principles:
- Intent-Based Classification: Eliminate strict liability for substances that have clear, documented medical necessity for an athlete's diagnosed impairment.
- Administrative Amnesty: Allow retroactive TUE approval for established prescriptions when there is zero evidence of deliberate performance enhancement or masking.
- Proportional Penalties: Stop handing out two-year bans for procedural errors. A reprimand or administrative fine suffices for a late filing; reserve multi-year suspensions for actual biological fraud.
Until anti-doping agencies stop treating paperwork errors as moral failures, every headline celebrating a two-year ban is not a triumph for clean sport. It is an admission of institutional incompetence.
Stop applauding the destruction of athletes' lives over administrative technicalities. Demand a system that knows the difference between a cheat and a patient.
